72 lines
4.0 KiB
TeX
72 lines
4.0 KiB
TeX
\documentclass[8pt]{article}
|
||
\usepackage[UTF8]{ctex} % 设置字体
|
||
\usepackage{tabularray} % longtblr核心宏包
|
||
\usepackage{xcolor} % 颜色支持
|
||
|
||
\usepackage{geometry}
|
||
\usepackage{textcomp}
|
||
\usepackage[english]{babel}
|
||
\geometry{
|
||
a4paper, % A4纸张
|
||
left=1.5cm, % 左页边距
|
||
right=1.5cm, % 右页边距
|
||
top=2cm, % 上页边距
|
||
bottom=2cm, % 下页边距
|
||
}\linespread{1.05}\definecolor{tablegray}{RGB}{250,231,232}
|
||
|
||
\begin{document}
|
||
|
||
\begin{longtblr}[
|
||
caption = {Table 3 Efficacy/effectiveness and safety results in phase III clinical trials},
|
||
label = {tab-1038},
|
||
]{
|
||
% 你指定的列格式：自定义宽度比例 + 左对齐 + 防止文字溢出
|
||
colspec={X[0.3] X[0.3] X[0.3] X[0.3] X[0.3] X[0.3] X[0.3] X[0.3] X[1] },
|
||
width = \textwidth, % 表格宽度占满行宽（配合X列生效）
|
||
rowhead = 1, % 表头跨页重复
|
||
% 三线表核心配置
|
||
hline{1} = {1pt}, % 顶线（粗）
|
||
hline{2} = {0.5pt}, % 表头分隔线（细）
|
||
hline{Z} = {1pt}, % 底线（粗）
|
||
% 隔行变色 + 样式优化
|
||
row{1} = {bg=gray!30, font=\bfseries, abovesep=5pt, belowsep=5pt}, % 表头样式
|
||
row{even} = {bg=tablegray}, % 偶数行浅灰
|
||
row{odd} = {bg=white}, % 奇数行白色
|
||
rowsep = 4pt, % 行间距
|
||
}
|
||
% 表头
|
||
\textbf{Author, Year} & \textbf{Sample size} & \textbf{Intervention} & \textbf{Target} & \textbf{Comparator} & \textbf{Efficacy} & \textbf{Comparison of intervention and comparator} & \textbf{Safety} & \textbf{Safety in the intervention} \\
|
||
Sidiqi, 2023 \textcolor[HTML]{0082AA}{[61]} & 208 & Cilta-cel & BCMA & PVd or DPd & PFS & HR: 0.26; \textit{P} < 0.0001 & CRS, ICANS & CRS: 76\% any grade, 1\% Grade 3; ICANS: 5\% any grade, 0\% Grade 3/4; Other neurotoxicities: 17\% any grade, 2\% Grade 3/4 (including cranial nerve paralysis 9\%, peripheral neuropathy 3\%, and one case of Grade 1 movement/neurocognitive-related AE) \\
|
||
Rodriguez-Otero, 2023 \textcolor[HTML]{0082AA}{[62]} & 386 & Ide-cel & BCMA & Standard regimens (five different regimens) & PFS & HR for disease progression or death: 0.49 (95\% CI, 0.38 to 0.65; \textit{P} < 0.001) & Grade 3 or 4 adverse events & CRS: 93\% \\
|
||
San-Miguel, 2024 \textcolor[HTML]{0082AA}{[63]} & 419 & Cilta-cel & BMCA & SOC & Overall survival & 30mo OS 76.4\% vs 63.8\% (HR 0.55) & CRS, ICANS & ≥ G3 CRS: 1\%, ICANS: 0\% \\
|
||
Ailawadhi, 2024 \textcolor[HTML]{0082AA}{[57]} & 386 & Ide-cel & BMCA & SOC & mPFS & mPFS 13.3 vs 4.4 mo (HR 0.49) & CRS, ICANS & ≥ G3 CRS: 0\%, ICANS: 2\% \\
|
||
\end{longtblr}
|
||
|
||
\begin{longtblr}[
|
||
caption = {Table 4 Infusion schedule, target dose, and in-vivo persistence},
|
||
label = {tab-1039},
|
||
]{
|
||
% 你指定的列格式：自定义宽度比例 + 左对齐 + 防止文字溢出
|
||
colspec={X[0.3] X[0.6] X[1] X[1] },
|
||
width = \textwidth, % 表格宽度占满行宽（配合X列生效）
|
||
rowhead = 1, % 表头跨页重复
|
||
% 三线表核心配置
|
||
hline{1} = {1pt}, % 顶线（粗）
|
||
hline{2} = {0.5pt}, % 表头分隔线（细）
|
||
hline{Z} = {1pt}, % 底线（粗）
|
||
% 隔行变色 + 样式优化
|
||
row{1} = {bg=gray!30, font=\bfseries, abovesep=5pt, belowsep=5pt}, % 表头样式
|
||
row{even} = {bg=tablegray}, % 偶数行浅灰
|
||
row{odd} = {bg=white}, % 奇数行白色
|
||
rowsep = 4pt, % 行间距
|
||
}
|
||
% 表头
|
||
\textbf{Product} & \textbf{Infusion schedule} & \textbf{Target dose} & \textbf{Reported in }\textbf{vivo persistence*} \\
|
||
Cilta-cel & Single & 0.75 × 10⁶ CAR$^{{+}}$ cells/kg & Median 277 days \\
|
||
Ide-cel & Single & 150 × 10$^{{6}}$ to 450 × 10$^{{6}}$ cells & Median 4.2 months \\
|
||
CT103A & Single & 1.0 × 10⁶ cells/kg & Detectable ≥ 12 months (61\%) \\
|
||
LCAR-B38M & 3 split (20/30/50\%) & 0.5 × 10⁶ cells/kg & Median 8 months \\
|
||
ALLO-715 & Single & 320 × 10⁶ cells & < 28 days \\
|
||
\end{longtblr}
|
||
|
||
\end{document} |